PLx Pharma Inc.’s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August
July 12, 2021 16:30 ET
|
PLx Pharma Inc.
SPARTA, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected...
PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences
June 09, 2021 16:30 ET
|
PLx Pharma Inc.
SPARTA, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected...
PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business Update
May 14, 2021 06:50 ET
|
PLx Pharma Inc.
– VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsules, gain FDA approval – – Company secured $71.4 million of gross proceeds in an underwritten public offering of common...
PLx Pharma Inc. to Discuss 2021 First Quarter Financial Results on May 14, 2021 Conference Call and Provide Business Update
May 03, 2021 16:30 ET
|
PLx Pharma Inc.
SPARTA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected...
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
March 12, 2021 06:50 ET
|
PLx Pharma Inc.
-- Received FDA approval of sNDAs for both VAZALORE 325 mg and 81 mg, the first-ever novel, liquid-filled aspirin capsule -- -- U.S. commercial launch of VAZALORE planned for third quarter...
PLx Pharma Inc. to Present at the Oppenheimer 31st Annual Healthcare Conference
March 11, 2021 17:00 ET
|
PLx Pharma Inc.
SPARTA, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical company focused on its clinically-validated and patent-protected...
PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update
March 04, 2021 17:30 ET
|
PLx Pharma Inc.
SPARTA, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and...
PLx Pharma Inc. Prices $63 Million Underwritten Public Offering of Common Stock
March 03, 2021 08:48 ET
|
PLx Pharma Inc.
SPARTA, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and...
PLx Pharma Inc. Announces Proposed Public Offering of Common Stock
March 02, 2021 16:05 ET
|
PLx Pharma Inc.
SPARTA, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on its clinically-validated and...
PLx Pharma Receives FDA Approval of SNDAs for Both VAZALORE 325 mg and 81 mg
March 01, 2021 06:50 ET
|
PLx Pharma Inc.
-- VAZALORE is the first ever liquid-filled aspirin capsule with an innovative delivery platform indicated as a pain reliever, fever reducer and for aspirin therapy in vascular indications – --...